Quality & complianceOfficial

California lab and owner pay $1.25m to settle False Claims Act kickback allegations

🇺🇸 HHS OIG · Fri 13 Nov 2026

Lab Genomics LLC and its owner, Leena Dalal, have agreed to pay the US government $1.25m over alleged illegal payments to marketers, according to HHS OIG.

Lab Genomics LLC, a clinical laboratory in Fountain Valley, California, and its owner, Leena Dalal, have agreed to pay $1.25m to the United States to resolve allegations of paying illegal kickbacks to marketers. HHS OIG published the item on 13 November 2026.

The government alleged that the payments violated the False Claims Act. The settlement resolves those allegations; the source text does not describe the terms in further detail.

The action is listed with an agency of the US Department of Justice and dated 6 November 2026. It is categorised under both criminal and civil enforcement types. The source does not say what the marketers did, how the payments were structured, or what period or claims were involved.

As general context, the False Claims Act allows the federal government to pursue liability for false or fraudulent claims for payment, and it is commonly used in healthcare enforcement where arrangements are alleged to taint claims submitted to federal programmes.

What it means for your team

  • Compliance teams at laboratories should keep reviewing commission-based and third-party marketing arrangements for kickback risk.
  • The settlement involves both a company and its owner, so individual accountability is part of the enforcement picture.
  • The public notice gives few details, so organisations should rely on the underlying Department of Justice materials for any further specifics.

Official source: HHS OIG ↗

Article written by VigiEye from the official source (HHS OIG). AI-assisted; check the source before acting.

More Quality & compliance All →